Dr. Edelman has had ties to working and collaborating and dozens of disclosures all leading back to Bristol Myers Squibb and it is now clear that SOMETHING forced Dr. Edelman into changing his mind to back off of working with Peregrine Pharmaceuticals and back into the Bristol Myers Squibb scene.... what would that be? This may be just one of many more puzzle pieces that will blow the lid off of how corrupt certain Big Pharma can be
Some don't think that it will go public and some are just collecting so much info that there will much more than enough info to make solid connections
Dr Martin Edelman went on record saying he was looking forward to working with Bavituximab as he went to UNM and left around June 2014 after just 1 year ....and who shows up there at UNM?
....and now Dr Rixe working / PI with a PS Targeting drug from Bexion....another strange twist to point out but Dr Yanis Boumber not no more at UNM??!!
One should read the Dr Martin Edelman posts part I II III ..etc and realize how he went to UNM and lured back and it is as if some groups do not like when anyone of value would be about to give PS Targeting more value because all three of these docs now just bouncing around....all strings pulled by ??? to avoid PS Targeting advancements ??
---------------
United States, New Mexico University of New Mexico Cancer Center Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Teresa L Stewart, MS,CRCP 505-925-0367 TStewart@salud.unm.edu Principal Investigator: Yanis Boumber, MD, PhD Principal Investigator: Olivier Rixe, MD, PhD https://www.clinicaltrials.gov/show/NCT02859857
Even more bizarre like being poached back and forth is the other PI Dr Yanis Boumber listed above at UNM says below he left UNM for Fox Chase ( where Dr Martin Edelman just landed recently...)
Therapeutics Program OCTOBER 3, 2016 Yanis Boumber, MD, PhD Yanis Boumber, MD, PhD PHILADELPHIA (October 3, 2016) – Yanis Boumber, MD, PhD, will join the Department of Thoracic Medical Oncology and the Molecular Therapeutics Program at Fox Chase Cancer Center starting Oct. 3.
Boumber first joined Fox Chase’s Department of Medical Oncology in 2013 and now returns to Fox Chase from the University of New Mexico Comprehensive Cancer Center.